Am J Health-Sys Ph:临床视频远程医疗为偏远地区提供临床药学服务

2017-09-15 吴星 环球医学

针对偏远地区看病难的问题,各国的远程医疗技术都在逐步展开。2017年7月,《Am J Health Syst Pharm》上发表了一项关于使用临床视频远程医疗为偏远地区提供临床药学服务的研究。研究证实了远程医疗在为偏远地区提供医疗服务方面具有较好效果。



针对偏远地区看病难的问题,各国的远程医疗技术都在逐步展开。2017年7月,《Am J Health Syst Pharm》上发表了一项关于使用临床视频远程医疗为偏远地区提供临床药学服务的研究。研究证实了远程医疗在为偏远地区提供医疗服务方面具有较好效果。

目的:描述美国阿拉斯加和西北部偏远地区多个退伍军人事务部(VA)诊所使用视频会议和其他远程技术,扩展临床药学服务。

摘要:从2014年开始,基于爱达荷州博伊西VA医疗中心的VA远程馆中的临床药学专家就为16个诊所提供远程医疗服务。在一个远程模式中,在诊所护理工作人员的协助下,一名药剂师和其他地处偏远的初级护理小组成员(一名医疗提供者,一名医疗助理,一个社会工作者和一名心理学家)与VA诊所的退伍军人开展了远程医疗;该模式已被用于改善人口稀少地区退伍军人的医疗管理服务。在第二个VA远程医疗模式中,地处偏远的药剂师使用远程医疗技术,与患者所在地的初级护理小组成员一起参与了临床会诊;该模式允许在计划或无计划的临床药剂师缺席的情况下,按需远程覆盖。自从建立了远程医疗点,药剂师可以通过参与视频会谈,为超过1200例患有糖尿病、高血脂、高血压和其他慢病退伍军人提供其他基于远程健康的临床服务。

结论:在VA健康系统内,远程健康技术已经被证明是为偏远地区提供临床药学服务的一种有成本效益和受欢迎的方法。

原始出处:

Perdew C, et al. Innovative models for providing clinical pharmacy services to remote locations using clinical video telehealth. Am J Health Syst Pharm. 2017 Jul 15;74(14):1093-1098. doi: 10.2146/ajhp160625.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1942254, encodeId=eada1942254f7, content=<a href='/topic/show?id=947f8e53195' target=_blank style='color:#2F92EE;'>#药学服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87531, encryptionId=947f8e53195, topicName=药学服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Tue Aug 14 22:35:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861145, encodeId=3bc318611459d, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Aug 31 16:35:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621656, encodeId=63271621656a0, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sat Sep 16 22:35:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244267, encodeId=d2d924426ecb, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Sep 15 11:35:49 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244243, encodeId=ab9f244243a6, content=学了.........., beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Fri Sep 15 09:13:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244212, encodeId=a4dc24421227, content=药剂师的作用很大的, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Fri Sep 15 07:43:28 CST 2017, time=2017-09-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1942254, encodeId=eada1942254f7, content=<a href='/topic/show?id=947f8e53195' target=_blank style='color:#2F92EE;'>#药学服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87531, encryptionId=947f8e53195, topicName=药学服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Tue Aug 14 22:35:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861145, encodeId=3bc318611459d, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Aug 31 16:35:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621656, encodeId=63271621656a0, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sat Sep 16 22:35:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244267, encodeId=d2d924426ecb, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Sep 15 11:35:49 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244243, encodeId=ab9f244243a6, content=学了.........., beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Fri Sep 15 09:13:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244212, encodeId=a4dc24421227, content=药剂师的作用很大的, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Fri Sep 15 07:43:28 CST 2017, time=2017-09-15, status=1, ipAttribution=)]
    2018-08-31 shizhenshan
  3. [GetPortalCommentsPageByObjectIdResponse(id=1942254, encodeId=eada1942254f7, content=<a href='/topic/show?id=947f8e53195' target=_blank style='color:#2F92EE;'>#药学服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87531, encryptionId=947f8e53195, topicName=药学服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Tue Aug 14 22:35:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861145, encodeId=3bc318611459d, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Aug 31 16:35:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621656, encodeId=63271621656a0, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sat Sep 16 22:35:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244267, encodeId=d2d924426ecb, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Sep 15 11:35:49 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244243, encodeId=ab9f244243a6, content=学了.........., beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Fri Sep 15 09:13:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244212, encodeId=a4dc24421227, content=药剂师的作用很大的, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Fri Sep 15 07:43:28 CST 2017, time=2017-09-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1942254, encodeId=eada1942254f7, content=<a href='/topic/show?id=947f8e53195' target=_blank style='color:#2F92EE;'>#药学服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87531, encryptionId=947f8e53195, topicName=药学服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Tue Aug 14 22:35:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861145, encodeId=3bc318611459d, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Aug 31 16:35:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621656, encodeId=63271621656a0, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sat Sep 16 22:35:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244267, encodeId=d2d924426ecb, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Sep 15 11:35:49 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244243, encodeId=ab9f244243a6, content=学了.........., beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Fri Sep 15 09:13:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244212, encodeId=a4dc24421227, content=药剂师的作用很大的, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Fri Sep 15 07:43:28 CST 2017, time=2017-09-15, status=1, ipAttribution=)]
    2017-09-15 Y—xianghai

    学习了新知识

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1942254, encodeId=eada1942254f7, content=<a href='/topic/show?id=947f8e53195' target=_blank style='color:#2F92EE;'>#药学服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87531, encryptionId=947f8e53195, topicName=药学服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Tue Aug 14 22:35:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861145, encodeId=3bc318611459d, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Aug 31 16:35:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621656, encodeId=63271621656a0, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sat Sep 16 22:35:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244267, encodeId=d2d924426ecb, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Sep 15 11:35:49 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244243, encodeId=ab9f244243a6, content=学了.........., beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Fri Sep 15 09:13:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244212, encodeId=a4dc24421227, content=药剂师的作用很大的, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Fri Sep 15 07:43:28 CST 2017, time=2017-09-15, status=1, ipAttribution=)]
    2017-09-15 135****7952平儿

    学了..........

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1942254, encodeId=eada1942254f7, content=<a href='/topic/show?id=947f8e53195' target=_blank style='color:#2F92EE;'>#药学服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87531, encryptionId=947f8e53195, topicName=药学服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Tue Aug 14 22:35:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861145, encodeId=3bc318611459d, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Fri Aug 31 16:35:00 CST 2018, time=2018-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621656, encodeId=63271621656a0, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Sat Sep 16 22:35:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244267, encodeId=d2d924426ecb, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Sep 15 11:35:49 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244243, encodeId=ab9f244243a6, content=学了.........., beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Fri Sep 15 09:13:00 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244212, encodeId=a4dc24421227, content=药剂师的作用很大的, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Fri Sep 15 07:43:28 CST 2017, time=2017-09-15, status=1, ipAttribution=)]
    2017-09-15 flysky120

    药剂师的作用很大的

    0

相关资讯

2014年中国高血压年会在上海成功举办(有讲座视频)

相关会议视频请进入:http://edu.medsci.cn/course/serielist-1085890.html由中国高血压联盟、中华医学会心血管病学分会、国家心血管病中心及世界高血压联盟北京办公室联合主办,上海市高血压研究所、北京高血压联盟研究所与北京高血压防治协会共同承办的2014年中国高血压年会暨第十六届国际高血压及相关疾病学术研讨会于2014年9月11日-14日在上海成功举办。

上海中医药国际论坛,精彩视频集锦,阐述中医药未来发展趋势

中医药是我国独特的卫生资源、优秀的文化资源、有原创优势的科技资源、潜力巨大的经济资源、重要的生态资源。“上海中医药国际论坛”立足中国传统中医药学,发展现代中医科学,注重跨文化沟通与中医药服务贸易发展,邀请国内外医药领域权威专家做学术报告,旨在弘扬学术精神,推动中医药的国际传播,加速中医学科发展与多学科的交叉融合,促进学术研究与社会、经济生活的联系,为人们享有更健康美好的生活而努力。 上海中医

史上伟大的心脏急救视频

当今社会,工作节奏快、生活压力大,猝死时有发生。到底该如何正确、及时地拯救那些在你身边倒下的人们?赶快行动起来,伸出双手,挽救生命! 以下视频完美呈现了心脏骤停后错综复杂的急救生存链全过程,包括了最初的心肺复苏(CPR)、急救系统启动、便携式体外自动除颤仪(AED),以及专业医务人员使用除颤监护仪、电力心肺复苏系统及最新的机体冷却系统等内容。堪称史上最“伟大”的心脏急救全程演示视频。

移动视频,下一个移动医疗爆发点

移动视频,这个或许在十几年前还不敢想象的内容,如今却已是司空见惯的存在,伴随着互联网技术的不断发展,网络给人们生活带来便利的同时,也拉进了人与人之间的交流方式,让我们真正体会到“即使人各天涯,也能若比邻”的便捷网络生活。据中国互联网信息中心统计数据显示,截至2014年6月,中国网络视频用户规模达4.39亿,较去年年底增加1057万人,用户增长率为2.5%。而这个数字正随着中国网民数量的增长而继

Am J Gastroenterol:视频饮食教育能改善肠道准备质量吗?

门诊结肠镜检查(CLS)能否成功取决于许多因素,包括患者的肠道准备情况。虽然CLS之前服用导泻剂可以提高肠道准备质量,但没有研究评估CLS之前饮食教育对CLS质量的影响。 我们创立了CLS之前的饮食教育视频,调查这项措施能否改善患者的肠道准备质量。 这项前瞻性随机试验使用聚乙二醇基进行肠道准备。然后将患者随机分配到干预组或无干预组。干预为4分钟的教育视频,详细说明了明确的液体饮食限制。

重磅推出:MedSci临床研究基础与实践课程!

为了让您掌握更多的临床研究知识,更好的开展高质量的临床研究。​MedSci正式推出《MedSci临床研究基础与实践》系列在线学习课程! 目前入驻讲师有深受各位喜爱的 MedSci张博士、马博士、朱博士以及阮博士,其后更有医学各领域的热门专家加入。敬请期待!​​ 本课程分4个单元,每个单元内含系列章节课程: 一、 临床研究设计和统计:临床研究设计、研究类型、研究对象选择、随机化问题、样本量计算